Press Releases
Catalent Adds Potent Manufacturing Capabilities at its Buenos Aires,...
Catalent, the leading global provider of advanced delivery technologies, development, and manufacturing, solutions for drugs, biologics, cell and gene therapies, and consumer health products, announced...
Press Releases
Novartis Cosentyx receives EU approval for first-line systemic treatment...
Novartis, a leader in immuno-dermatology and rheumatology, announced the EC has granted the approval for Cosentyx® (secukinumab) for the treatment of moderate-to-severe plaque psoriasis in...
Press Releases
Raremark launches the Xperiome patient-powered knowledge platform to deliver...
Raremark®, the leading online patient community in rare disease, has launched its patient-powered knowledge platform Xperiome™ to help the pharmaceutical industry deliver innovative new therapies...
Packaging & Labelling
Sharp has achieved landfill-free status across its global facility...
Sharp, part of UDG Healthcare plc, a global leader in contract packaging and clinical supply services, has achieved landfill-free status across its global facility network.
As...
Drug Research
Daiichi Sankyo and AstraZeneca Enter New Global Development and...
Daiichi Sankyo Company, Limited announced that it has entered into a global development and commercialization agreement with AstraZeneca for Daiichi Sankyo’s DS-1062, a TROP2 directed...
Clinical Trials
AbbVie Announces Positive Phase 3 Data for Atogepant in...
AbbVie announced that the Phase 3 ADVANCE trial evaluating the investigational medicine atogepant, an orally administered calcitonin gene-related peptide (CGRP) receptor antagonist (gepant) met its...
Press Releases
Sanofi and GSK agree with the UK government to...
Sanofi and GSK have reached an agreement, subject to final contract, with the UK government for the supply of up to 60 million doses of...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.